March 7, 2022
March Company Update
Dear friends, Colleagues and Shareholders, Mydecine has made strides towards our goals over the last few months! We continue to gain momentum as we reach significant milestones in our clinical trial…
January 24, 2022
What is Health Canada’s Special Access Program?
Health Canada's Special Access Program (SAP) enables drugs that are not marketed in Canada to be requested by practitioners for the treatment, diagnosis, or prevention of serious or…
January 7, 2022
3 Things Investors Should Know About Mydecine’s Artificial Intelligence & Machine Learning Drug Discovery Program
1. What does artificial intelligence (AI) and machine learning (ML) drug discovery mean? We are using a supercomputer to screen billions of molecules rapidly to determine new compounds that are…